Search details
1.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Article
in English
| MEDLINE | ID: mdl-34904799
2.
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada.
Br J Haematol
; 204(3): 805-814, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37886835
3.
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.
Oncologist
; 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38636951
4.
Fracture risk among patients with cancer compared to individuals without cancer: a population-based study.
Br J Cancer
; 129(4): 665-671, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37422530
5.
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario.
Br J Haematol
; 202(6): 1104-1118, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37474340
6.
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Oncologist
; 28(9): 799-803, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37226534
7.
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.
BMC Med Res Methodol
; 23(1): 179, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37537545
8.
Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based study.
BMC Cancer
; 22(1): 1133, 2022 Nov 04.
Article
in English
| MEDLINE | ID: mdl-36333707
9.
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes.
Ann Hematol
; 101(5): 1023-1030, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35190844
10.
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
J Natl Compr Canc Netw
; 20(6): 635-642.e9, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35714676
11.
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Value Health
; 25(7): 1157-1164, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35779942
12.
Association between diabetes and haematological malignancies: a population-based study.
Diabetologia
; 64(3): 540-551, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33409570
13.
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry.
J Natl Compr Canc Netw
; 19(6): 719-725, 2021 03 10.
Article
in English
| MEDLINE | ID: mdl-33691276
14.
Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework.
J Natl Compr Canc Netw
; 19(7): 815-820, 2021 02 26.
Article
in English
| MEDLINE | ID: mdl-33636693
15.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34053112
16.
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
Clin Trials
; 18(4): 500-504, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33866856
17.
Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
Br J Haematol
; 191(3): 396-404, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32304100
18.
Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival Time.
J Natl Compr Canc Netw
; 18(3): 278-285, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32135516
19.
Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?
J Natl Compr Canc Netw
; 17(12): 1489-1496, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31805528
20.
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer System.
Cancer
; 124(7): 1473-1482, 2018 04 01.
Article
in English
| MEDLINE | ID: mdl-29315535